Evidence map›Paper›PMID 31664161›Full record

ArticleJournal of human genetics2020

Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region.

Samuel B Anyona, Nicolas W Hengartner, Evans Raballah, John Michael Ong'echa, Nick Lauve, Qiuying Cheng, Paul W Fenimore, Collins Ouma, Christophe G Lambert, Benjamin H McMahon and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Long non-coding RNA transcripts inNon-coding RNA research · 2025
    Review
  3. Article
  4. Observational
  5. The roles of COX-2 in protozoan infection.Frontiers in immunology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Samuel B AnyonaUniversity of New Mexico-Kenya Global Health Programs, Kisumu and Siaya, Kenya.
Nicolas W HengartnerTheoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, USA.
Evans RaballahUniversity of New Mexico-Kenya Global Health Programs, Kisumu and Siaya, Kenya.
John Michael Ong'echaKenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
Nick LauveCenter for Global Health, University of New Mexico, Albuquerque, NM, USA.
Qiuying ChengCenter for Global Health, University of New Mexico, Albuquerque, NM, USA.
Paul W FenimoreTheoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, USA.
Collins OumaUniversity of New Mexico-Kenya Global Health Programs, Kisumu and Siaya, Kenya.
Christophe G LambertCenter for Global Health, University of New Mexico, Albuquerque, NM, USA.ORCID http://orcid.org/0000-0003-1994-2893
Benjamin H McMahonTheoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, USA.
Douglas J PerkinsUniversity of New Mexico-Kenya Global Health Programs, Kisumu and Siaya, Kenya. dperkins@salud.unm.edu.
University of New Mexico · USLos Alamos National Laboratory · USKenya Medical Research Institute · KE

Funding

Partnership for Global Health Research Training Program (Renewal)-Supplement for OBSSR, NCI, NCI-AIDS and NIDCDD43TW010543 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, DAVIDSON HOWES HAMER · 2017 to 2026
$12.1M
Harnessing the Malarial Immunity Omics Landscape in Vaccinated and Unvaccinated Children for Improved Therapeutic StrategiesR01AI130473 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Samuel Bonuke Anyona, Douglas Jay Perkins · 2018 to 2026
$5.6M
TRAINING AND RESEARCH ON SEVERE MALARIAL ANEMIAD43TW005884 · FIC · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Collins Ouma, Douglas Jay Perkins · 2002 to 2026
$5.2M
GENETIC BASIS OF SEVERE MALARIAL ANEMIAR01AI051305 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PERKINS, DOUGLAS JAY · 2002 to 2011
$4.7M
Dysregulation of the Human Ubiquitin Proteasome System in Pediatric Severe Malarial AnemiaK43TW011581 · FIC · MASENO UNIVERSITY · PI ANYONA, SAMUEL BONUKE · 2020 to 2023
$280k
FIC NIH HHS D43 TW005884FIC NIH HHS D43 TW010543FIC NIH HHS K43 TW011581NIAID NIH HHS R01 AI051305NIAID NIH HHS R01 AI130473
6 · The paper itself

Abstract

Cyclooxygenase-2 [(COX-2) or prostaglandin endoperoxide H2 synthase-2 (PTGS-2)] induces the production of prostaglandins as part of the host-immune response to infections. Although a number of studies have demonstrated the effects of COX-2 promoter variants on autoimmune and inflammatory diseases, their role in malaria remains undefined. As such, we investigated the relationship between four COX-2 promoter variants (COX-2 -512 C > T, -608 T > C, -765 G > C, and -1195 A > G) and susceptibility to malaria and severe malarial anemia (SMA) upon enrollment and longitudinally over a 36-month follow-up period. All-cause mortality was also explored. The investigation was carried out in children (n = 1081, age; 2-70 months) residing in a holoendemic Plasmodium falciparum transmission region of western Kenya. At enrollment, genotypes/haplotypes (controlling for anemia-promoting covariates) did not reveal any strong effects on susceptibility to either malaria or SMA. Longitudinal analyses showed decreased malaria episodes in children who inherited the -608 CC mutant allele (RR = 0.746, P = 1.811 × 10

Indexed as

AnemiaChildChild, PreschoolCyclooxygenase 2FemaleGenetic Predisposition to DiseaseGenotypeHaplotypesHumansInfantKenyaLongitudinal StudiesMalariaMalaria, FalciparumMalePolymorphism, Single NucleotideCyclooxygenase 2PTGS2 protein, human

Identifiers

PMID31664161
PMCPMC7255056
OpenAlexW2982344214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.